| Market Cap | 95.90M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -44.25M | Forward P/E | -23.48 | EPS next Y | 86.40% | 50D Avg Chg | -72.00% |
| Sales | 75.81M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -78.00% |
| Dividend | N/A | Price/Book | 0.36 | EPS next 5Y | - | 52W High Chg | -86.00% |
| Recommedations | - | Quick Ratio | 1.34 | Shares Outstanding | 68.06M | 52W Low Chg | 2.00% |
| Insider Own | - | ROA | -13.57% | Shares Float | 58.82M | Beta | 1.61 |
| Inst Own | - | ROE | -23.11% | Shares Shorted/Prior | -/- | Price | 1.41 |
| Gross Margin | 13.66% | Profit Margin | -58.36% | Avg. Volume | 42,935 | Target Price | - |
| Oper. Margin | -74.41% | Earnings Date | Feb 22 | Volume | 294,564 | Change | -7.90% |
The Valens Company Inc. operates as a cannabis consumer products company. It engages in manufacturing cannabinoid based products. The company provides proprietary cannabis processing services, as well as is involved in product development, manufacturing, and commercialization of cannabis consumer packaged goods. Its products are formulated for the recreational, health and wellness, and medical consumer segments and offers across various cannabis product categories. The company also manufactures, distributes, and sells a range of CBD products in the United States through its subsidiary Green Roads, and distributes medicinal cannabis products to international markets through its subsidiary Valens Australia. In addition, the company through Valens Labs, provides cannabis testing and research and development services. The company was formerly known as Valens Groworks Corp. and changed its name to The Valens Company Inc. in June 2020. The Valens Company Inc. is headquartered in Toronto, Canada.